For businesses, Supreme Court ruling provides a measure of clarity in health care calculations – The Boston Globe
“It’s good news for the biotech industry,” said Richard Pops, chief executive of Alkermes Inc. in Waltham. “This was a highly engineered and negotiated law. If it had been struck down in whole or in part, it would have created a lot of uncertainty.
Subscribe to LegalLaw247.Com Newsletter
